NASDAQ:SKIN - Beauty Health Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $26.11
  • Forecasted Upside: 78.35 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 9 Buy Ratings
  • 0 Strong Buy Ratings
$14.64
▲ +0.92 (6.71%)

This chart shows the closing price for SKIN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Beauty Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SKIN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SKIN

Analyst Price Target is $26.11
▲ +78.35% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Beauty Health in the last 3 months. The average price target is $26.11, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 78.35% upside from the last price of $14.64.

This chart shows the closing price for SKIN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 10 polled investment analysts is to buy stock in Beauty Health.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/4/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/2/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/31/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/29/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/27/2022
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/28/2022
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/28/2022

Latest Recommendations

  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/11/2022Canaccord Genuity GroupLower Price Target$27.00 ➝ $22.00High
5/11/2022DA DavidsonLower Price Target$35.00 ➝ $24.00High
5/11/2022Piper SandlerLower Price Target$26.00 ➝ $24.00High
4/28/2022Piper SandlerLower Price Target$31.00 ➝ $26.00Medium
3/14/2022BenchmarkBoost Price TargetBuy$18.00 ➝ $23.00High
3/11/2022JPMorgan Chase & Co.Initiated CoverageOverweight$24.00High
2/23/2022DA DavidsonBoost Price TargetBuy$32.00 ➝ $35.00High
1/7/2022William BlairInitiated CoverageOutperformMedium
12/23/2021Raymond JamesInitiated CoverageMarket PerformMedium
11/10/2021DA DavidsonBoost Price TargetBuy$26.00 ➝ $32.00High
10/7/2021Stifel NicolausInitiated CoverageBuy$33.00High
10/4/2021CowenInitiated CoverageOutperform$32.00Medium
9/1/2021Piper SandlerBoost Price TargetSell ➝ Overweight$27.00 ➝ $33.00High
8/11/2021DA DavidsonBoost Price TargetBuy$17.50 ➝ $26.00High
8/11/2021BenchmarkBoost Price TargetBuy$18.00 ➝ $25.00High
7/19/2021Jefferies Financial GroupInitiated CoverageBuy$22.00High
7/1/2021The Goldman Sachs GroupInitiated CoverageBuy$31.00High
6/28/2021BenchmarkBoost Price TargetBuy$16.00 ➝ $22.00Low
6/24/2021Piper SandlerInitiated CoverageOverweight$24.00Medium
6/1/2021DA DavidsonBoost Price TargetBuy$16.00 ➝ $17.50High
(Data available from 5/28/2017 forward)

News Sentiment Rating

0.98 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 22 very positive mentions
  • 14 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
10/30/2021
  • 24 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/29/2021
  • 30 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
12/29/2021
  • 21 very positive mentions
  • 30 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
1/28/2022
  • 42 very positive mentions
  • 19 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
2/27/2022
  • 21 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
3/29/2022
  • 25 very positive mentions
  • 19 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/28/2022
  • 49 very positive mentions
  • 31 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
5/28/2022

Current Sentiment

  • 49 very positive mentions
  • 31 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Beauty Health logo
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Read More

Today's Range

Now: $14.64
Low: $13.77
High: $14.73

50 Day Range

MA: $14.39
Low: $10.60
High: $18.70

52 Week Range

Now: $14.64
Low: $9.94
High: $30.17

Volume

1,862,821 shs

Average Volume

2,267,106 shs

Market Capitalization

$2.19 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.73

Frequently Asked Questions

What sell-side analysts currently cover shares of Beauty Health?

The following Wall Street research analysts have issued research reports on Beauty Health in the last twelve months: Benchmark Co., Canaccord Genuity Group Inc., Cowen Inc, DA Davidson, Jefferies Financial Group Inc., JPMorgan Chase & Co., Piper Sandler, Raymond James, Stifel Nicolaus, The Goldman Sachs Group, Inc., William Blair, and Zacks Investment Research.
View the latest analyst ratings for SKIN.

What is the current price target for Beauty Health?

0 Wall Street analysts have set twelve-month price targets for Beauty Health in the last year. Their average twelve-month price target is $26.11, suggesting a possible upside of 78.4%.
View the latest price targets for SKIN.

What is the current consensus analyst rating for Beauty Health?

Beauty Health currently has 1 hold rating and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SKIN will outperform the market and that investors should add to their positions of Beauty Health.
View the latest ratings for SKIN.

How do I contact Beauty Health's investor relations team?

Beauty Health's physical mailing address is 1819 West Avenue Bay 2, Miami Beach FL, 33139. The company's listed phone number is 800-603-4996 and its investor relations email address is https://investors.beautyhealth.com. The official website for Beauty Health is hydrafacial.com. Learn More about contacing Beauty Health investor relations.